•Colabor Group completed a transaction with Colabor 2026 L.P., a member of Financière Outremont, which acquired substantially all assets of the Company.
•The closing marks the completion of four transactions contemplated under the sale and investment solicitation process supervised by the Superior Court of Québec.
•Republic Power Group Limited acquired a 10% equity interest in NVC Partners Limited, a firm focused on blockchain infrastructure for RWA tokenization.
•The Brazilian Ministry of Agriculture and Livestock published Ordinance No. 1617 prohibiting the importation, manufacture, and use of performance-enhancing feed additives containing certain antimicrobials.
•Analysts anticipate Brown & Brown to report EPS of $1.36 and revenue of $1.89 billion for the first quarter.
•Investors are monitoring stabilization in commercial property insurance rate declines and the integration of the Accession Risk Management Group acquisition.
•Solidion Technology plans to file a complaint with the U.S. International Trade Commission (ITC) seeking remedies under Section 337 of the Tariff Act of 1930.
•The company accuses large, well-known foreign entities of repeated use of its foundational battery technology portfolio and cutting-edge materials.
•Brazilian authorities have moved to shut down 27 prediction market platforms, including Kalshi, Polymarket, and PredictIt.
•New rules ban contracts tied to sports, politics, and entertainment, allowing only those linked to economic indicators like inflation and interest rates.
•The Brazilian Ministry of Finance justified the ban as a measure to reduce household debt and protect users from gambling-like activities.
•Iran has reportedly offered a new proposal to reopen ship traffic in the Strait of Hormuz while postponing nuclear discussions.
•President Trump stated a peace deal could be reached via telephone rather than face-to-face meetings, while warning of strikes on Iranian oil infrastructure.
•Iranian Foreign Minister Araghchi visited Russia for talks with President Putin while sending written messages to the US via Pakistani intermediaries.
•BioMarin Pharmaceutical completed the acquisition of Amicus Therapeutics in an all-cash transaction for a total equity value of approximately $4.8 billion.
•The acquisition was executed at $14.50 per share, adding Galafold, Pombiliti, and Opfolda to BioMarin's commercial portfolio.